SPPH Spencer Pharmaceutical Inc (CE)

Hail First Pharma Inc. announced today the hiring of Long Island based DGR Advisors LLC as its investor relations firm.

DGR Advisors LLC will immediately take on the responsibility of all incoming calls from investors inquiring on the Spencer Pharmaceutical (PINKSHEETS: SPPH) buy-out transaction as well as its initial public offering. DGR Advisors LLC has been retained for a 12 month period and will be remunerated in cash, stock and options of Hail First Pharma Inc. for a total compensation of $120,000 and whereby the agreement may be renewed for an additional 12 months.

"DGR Advisors LLC is run by Robert Albi a seasoned Wall Street professional, which comes highly recommended," said Hussain Al-Awaid, Chairman of Hail First Pharma Inc. "We opted for Mr. Albi, because our immediate need is for incoming inquiries and he has extended experience in dealing with public transactions such as the current buy-out transaction and our IPO," further added Mr. Al-Awaid.

About Hail First Pharma

Hail First Pharma is a pharmaceutical company specializing in acquiring, licensing and distributing of diabetic drugs, drug delivery technology, nutritional products and medical equipment.

Important Information About Forward-Looking Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company's website does not constitute a part of this release.

Contact: Hail First Pharma Inc. Hussain Al-Awaid Chairman hailfirstpharma@gmail.com DRG Advisors LLC Robert Albi President Tel. 516-351-8562